Status:
COMPLETED
Autoregulation Assessment During Liver Transplantation
Lead Sponsor:
Johns Hopkins University
Conditions:
Liver Failure
Liver Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
Patients with liver failure undergoing liver transplantation often have clinical or sub-clinical encephalopathy that may lead to increased intracranial pressure. The latter may lead to abnormal regula...
Detailed Description
Hepatic encephalopathy complicating chronic liver failure in patients undergoing liver transplantation increases the risk for adverse outcomes including mortality. Even mild hepatic encephalopathy may...
Eligibility Criteria
Inclusion
- Age \> 18 years old and undergoing liver transplantation.
Exclusion
- Clinical instability as judged by the attending physicians whereby autoregulation monitoring may interfere with clinical care.
- Women of child bearing potential require a negative urine human chorionic gonadotropin (HCG) test to be enrolled.
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01425385
Start Date
September 1 2011
End Date
September 1 2012
Last Update
August 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287